You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 28, 2015

Animal Feed Control: An Update on Thailand’s Legislation

Subscribe to Updates
Informed Counsel

Thailand’s roadmap of food safety, which was approved in 2004, aims to promote the Kingdom as the “kitchen of the world.” Animal feed, i.e., food given to farm animals, plays a major role in the food safety regime—it is part of the stages of food production, dubbed “farm-to-table,” and is an integral component in the overarching food chain. Animal feed must be as safe as meat for human consumption, and therefore registration, inspection, and control of animal feed are vigorously regulated by the regulatory authorities.

The Department of Livestock Development (DLD), Ministry of Agriculture and Cooperatives (MoAC), is the main authority responsible for putting in place a system for the management and control of animal feed. With the tremendous growth in the animal feed business, a new government unit, the Division of Animal Feed and Veterinary Products Control, was established within the DLD on September 26, 2013. This unit is responsible for the control of animal feed and hazardous substances for use in livestock production, as stipulated in the Animal Feed Quality Control Act and the Hazardous Substance Act, respectively.

Due to the rapid evolution of technology, as well as innovation in animal feed and husbandry, animal feed businesses in Thailand have expanded significantly. Much like the changes in food safety and technology, the law controlling animal feed in Thailand has evolved over time. Animal feed was previously regulated under the Animal Feed Quality Control Act B.E. 2506 (1963 Act). The 1963 Act was replaced with the Animal Feed Quality Control Act B.E. 2525 (1983 Act). Then, in 1999, there was an amendment of the Act. And very recently, the Animal Feed Quality Control Act B.E. 2558 (2015 Act) was announced in the Royal Gazette, which came into force on March 5, 2015.

Under the 2015 Act, “specific control animal feed”  must be registered prior to domestically manufacturing or importing animal feed into the Kingdom of Thailand. This term was not defined under the previous Act. The term is very broad in meaning, as it covers feed that has an impact on socioeconomic problems, feed that will probably harm animals, or feed that will have an effect on consumers of meat.

In the future, the MoAC minister will announce the type, quality standard, conditions, and requirements for registration of such animal feed. The types of animal feed that currently require registration include premix, milk products for animals, feed supplements, feed mixed with veterinary drugs, and more.

Veterinary drugs, on the other hand, are regulated by the Thai Food and Drug Administration. Animal drugs must be registered, following the Drug Act B.E. 2510 (1967), as amended. While a drug product license can be transferred from one juristic person to another, an animal feed registration license cannot be transferred. In addition, if the registered animal feed has not been manufactured or imported for two years, the MoAC minister has the power to revoke the registration license of such animal feed. These are the important precautions that animal feed companies should keep in mind.

The 2015 Act allows officers to inspect premises for the importation or manufacturing of animal feed during the daytime, in cases where unlawful action is suspected. Officers may sample the animal feed in a sufficient quantity for further analysis and testing. Under the 2015 Act, officers are also empowered to issue a requisition letter to call persons to provide testimony or submit documents for further consideration. In addition, the 2015 Act also includes additional provisions regarding the issuance of quality assurance certificates by the DLD and the termination of business.

The 2015 Act is a good sign that the responsible authorities are taking measures to preserve the wellbeing of animals and ensure food safety. Those in the animal feed business should closely monitor animal-feed-related ministerial regulations, which will likely be issued in the near future. It is expected that the 2015 Act will improve the registration and surveillance of animal feed, and ultimately, will ensure greater safety for meat consumers.

Download Full Article
Related Professionals

Industries

Life Sciences

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

February 22, 2021
Following the recent imposition of sanctions on Myanmar individuals and companies by the US, the UK and Canada have now imposed new sanctions. As with the US sanctions, these new measures impact UK and Canadian citizens and companies, and non-UK and non-Canadian companies and citizens with interests in those jurisdictions. The EU has indicated that it is planning to issue similar sanctions in the near future. New UK Sanctions In addition to the 16 individuals already sanctioned by the UK government, on February 18, 2021, the UK government announced that three individuals have been sanctioned for serious human rights violations and are now subject to asset freezes and travel bans. The full list of Myanmar individuals and companies sanctioned by the UK is available on the website of the Office of Financial Sanctions Implementation. Breaches of UK financial sanctions are criminal offences punishable in the UK by up to 7 years imprisonment and heavy fines. New Canadian Sanctions Also on February 18, timed to coincide with the UK sanctions, new Canadian sanctions were imposed on nine individuals. As with the UK, Canada already had a number of individuals in the Myanmar military on its sanctions list, and the new additions bring the total number of individuals sanctioned by Canada to 54. All assets of these individuals in Canada are now frozen, and they are banned from travelling to Canada. Canadian businesses or entities may not do business with any of the 54 individuals. Full details of the impact of the sanctions are available on the Government of Canada’s website, as is a database of the Myanmar individuals and companies subject to them. Breach of Canadian sanctions carries with it up to 5 years’ imprisonment in Canada and/or a large fine. Other Countries The EU is reportedly drawing up sanctions
Read More
February 18, 2021
As you will no doubt know, on February 1, 2021, the Myanmar military declared a state of emergency in Myanmar for a period of one year. State Counsellor Daw Aung Sang Su Kyi was detained, as were the president and various significant political and civil leaders. Min Aung Hlaing, commander-in-chief of the Tatmadaw (Myanmar armed forces) has installed himself as chairman of the State Administration Council, the current administration. New sanctions The reaction of the Biden administration has been swift. On February 10, 2021, President Biden issued Executive Order 14014, which provides bases to impose sanctions on individuals and companies deemed by the US to, among other things: operate in the defense sector of Myanmar; be responsible for policies that undermine democratic processes in Myanmar; have taken actions to undermine democratic processes or institutions, or prohibit, limit, or penalize the exercise of free speech, in Myanmar; or be a spouse or child of the foregoing. On the next day, February 11, the US Office of Foreign Assets Control (OFAC), imposed sanctions under the new executive order on ten individuals—including General Min Aung Hlaing—and three companies, including Cancri Gems & Jewelry Co, Myanmar Imperial Jade Co, and Myanmar Ruby Enterprise.  All such individuals and companies have now been designated on the US list of specially designated nationals (SDNs). Effect of sanctions As a result of such sanctions, the property of these individuals or companies that is located in the US or is under the possession or control of US companies and citizens is frozen, and US companies and citizens are generally prohibited from dealing deal with any such property.  Reportedly, roughly USD 1 billion of funds belonging to the individuals and companies blocked on February 11 are located in the US and thus now frozen. The SDN list As many
Read More
February 1, 2021
The latest edition of Practical Law’s Life Sciences Global Guide features contributions from Tilleke & Gibbins attorneys in the firm’s Yangon office. One of the sections they have provided for the Myanmar chapter of this Q&A-style guide to life sciences regulatory frameworks worldwide is “Medicinal Product Regulation and Product Liability in Myanmar.” The section includes discussion of a range of regulatory issues related to the marketing and selling of pharmaceutical products, including the following topics: Regulatory overview: Authorities, scope, and general procedures for pharmaceuticals, biologicals, and medical devices and health care IT Pricing, government funding, and reimbursement: National health care system, price regulation, and reimbursement Clinical trials Manufacturing and distribution Marketing: Authorization for marketing medicinal products, parallel imports and cross-border trade in medicines Restrictions on dealings with health care professionals Selling restrictions Advertising and promotion Data privacy Packaging, labeling, and tracking Product safety, quality, and liability Local establishment, representation, and residency requirements Reform The full “Medicinal Product Regulation and Product Liability in Myanmar” section can be accessed on the Practical Law website. Practical Law, produced by Thomson Reuters, is the world’s leading legal know-how resource for business lawyers, publishing a huge range of guides covering hundreds of jurisdictions and practice areas. Tilleke & Gibbins also supplied “Pharmaceutical IP and Competition Law in Myanmar,” which was published in the Life Sciences Global Guide  at the same time.
Read More
February 1, 2021
Attorneys from Tilleke & Gibbins in Myanmar have contributed to the latest edition of Practical Law’s online Life Sciences Global Guide. The guide is a Q&A-style overview of the regulatory frameworks for the life sciences industry across multiple jurisdictions worldwide, and this year the Myanmar chapter includes two sections, one of which is “Pharmaceutical IP and Competition Law in Myanmar.” This section runs through the country’s legal and regulatory environment for patents and trademarks—particularly as they relate to pharmaceutical business in the jurisdiction. The section then turns to IP and competition law issues, with questions and answers focusing on how the country’s competition laws and regulations affect the pharmaceutical sector. Readers are also given information on how to properly comply with Myanmar law on competition, including when it comes to licensing of medicines and pharmaceutical technology. The full Pharmaceutical Intellectual Property and Competition Law in Myanmar guide can be accessed on the Practical Law website. Practical Law, produced by Thomson Reuters, is the world’s leading legal know-how resource for business lawyers, publishing a huge range of guides covering hundreds of jurisdictions and practice areas. Tilleke & Gibbins also supplied the “Medicinal Product Regulation and Product Liability in Myanmar,” which Practical Law published in its Life Sciences Global Guide  at the same time.
Read More